Efficacy and safety of Qili Qiangxin Capsule in the adjuvant treatment of ischemic cardiomyopathy with heart failure: a systematic review and meta-analysis

Efficacy and safety of Qili Qiangxin Capsule in the adjuvant treatment of ischemic cardiomyopathy with heart failure: a systematic review and meta-analysis

Objective: To evaluate the efficacy and safety of Qili Qiangxin Capsule (QLQXC) combined with western medicine in patients with ischemic cardiomyopathy (ICM) comorbid with heart failure (HF) for clinical application. Methods: We searched relevant references in Chinese databases including China Natio...

Full description

Bibliographic Details
Main Authors:	Yin Ziwei, Zheng Huizhen, Guo Zhihua
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-12-01
Series:	Digital Chinese Medicine
Subjects:	Qili Qiangxin Capsule (QLQXC) Ischemic cardiomyopathy (ICM) Heart failure (HF) Meta-analysis Chinese patent medicine Left ventricular ejection fraction (LVEF)
Online Access:	http://www.sciencedirect.com/science/article/pii/S258937772400003X

Similar Items

Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials
by: Jingjing Wei, et al.
Published: (2022-04-01)

Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis
by: Qian Xiang, et al.
Published: (2022-04-01)

Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism
by: Xiaoxiao Xing, et al.
Published: (2023-01-01)

Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms
by: Tongxing Wang, et al.
Published: (2023-11-01)

The transition and outcomes of perioperative low ejection fraction status in cardiac surgical patients
by: Jun Zhong, et al.
Published: (2021-12-01)

Left Ventricular Global Longitudinal Strain Is Associated With Cardiovascular Outcomes in Patients Who Underwent Permanent Pacemaker Implantation
by: Dae-Young Kim, et al.
Published: (2021-07-01)

Network pharmacology and molecular docking analysis on Shenfu Qiangxin indicate mTOR is a potential target to treat heart failure
by: Peilin Zou, et al.
Published: (2024-03-01)

Pacing-induced cardiomyopathy in chronic right ventricular apical pacing: a midterm follow-up study
by: Erdal Safak, et al.
Published: (2019-07-01)

Significance of preoperative left ventricular ejection fraction in 5-year outcome after isolated CABG
by: Aida Fallahzadeh, et al.
Published: (2021-12-01)

The Role of Left Ventricular Ejection Fraction and Left Ventricular Outflow Tract Velocity-Time Integral in Assessing Cardiovascular Impairment in Septic Shock
by: Konstantinos Spathoulas, et al.
Published: (2022-10-01)

Realization and Technology Acceptance Test of a Wearable Cardiac Health Monitoring and Early Warning System with Multi-Channel MCGs and ECG
by: Wen-Yen Lin, et al.
Published: (2018-10-01)

Characteristics of syncope in patients with dilated cardiomyopathy
by: Abdel-Hadi Rami, et al.
Published: (2016-04-01)

Acute kidney injury predicts poor left ventricular function for patients with peripartum cardiomyopathy
by: Jiajia Zhu, et al.
Published: (2021-04-01)

Influence of standard modifiable risk factors on ventricular tachycardia after myocardial infarction
by: Tejas Deshmukh, et al.
Published: (2023-10-01)

Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT)
by: Charlotte Stephansen, et al.
Published: (2018-11-01)

Long-term outcomes of non-ischemic dilated cardiomyopathy patients with left ventricular ejection fraction ≤19% on medical therapy
by: Sourabh Agstam, et al.
Published: (2020-11-01)

Myocardial Strain and Association With Clinical Outcomes in Danon Disease: A Model for Monitoring Progression of Genetic Cardiomyopathies
by: Quan M. Bui, et al.
Published: (2021-12-01)

Multinational cost‐effectiveness analysis of empagliflozin for heart failure patients with ejection fraction >40%
by: Spyros Kolovos, et al.
Published: (2023-12-01)

Better CRT Response in Patients Who Underwent Atrioventricular Node Ablation or Upgrade From Pacemaker: A Nomogram to Predict CRT Response
by: Pei-Lin Xiao, et al.
Published: (2021-11-01)

Changes in left ventricular systolic function after transcatheter patent ductus arteriosus closure in premature infants
by: Aravinth Karunanandaa, et al.
Published: (2023-01-01)

Hypertrophic Cardiomyopathy
by: Polakit Teekakirikul, MD, et al.
Published: (2021-09-01)

Peripartum cardiomyopathy in an elderly woman: A case report
by: Ojas Bondre, et al.
Published: (2023-01-01)

Factors Associated With the Improvement of Left Ventricular Systolic Function by Continuous Positive Airway Pressure Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Obstructive Sleep Apnea
by: Ryo Naito, et al.
Published: (2022-03-01)

CORONARY ANGIOPLASTY AND STENTING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
by: A. N. Samko, et al.
Published: (2016-02-01)

A case of sepsis‐induced cardiomyopathy successfully treated with venoarterial extracorporeal membrane oxygenation
by: Keigo Sato, et al.
Published: (2023-01-01)

Left Ventricular Noncompaction Masquerading as Hypertrophic Nonobstructive Cardiomyopathy
by: Praveen Rermal Veedu, et al.
Published: (2023-01-01)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
by: Robert J.H. Miller, et al.
Published: (2022-06-01)

Tako-tsubo cardiomyopathy
by: Hassan A. Mohamed
Published: (2007-01-01)

Insulin-like growth factor binding protein 2: a core biomarker of left ventricular dysfunction in dilated cardiomyopathy
by: Wei Yu, et al.
Published: (2023-10-01)

Parasitic Load Correlates With Left Ventricular Dysfunction in Patients With Chronic Chagas Cardiomyopathy
by: Maykon Tavares de Oliveira, et al.
Published: (2021-09-01)

Are We Getting Closer to Risk Stratification in Left Ventricular Noncompaction Cardiomyopathy?
by: John L. Jefferies
Published: (2018-10-01)

Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis
by: Øyvind H. Lie, et al.
Published: (2021-04-01)

Pregnancy outcome in patients presented with Peripartum Cardiomyopathy: A five-year study in a tertiary care centre
by: Lipika Adhikari, et al.
Published: (2022-03-01)

Multimodality Cardiac Imaging in Cardiomyopathies: From Diagnosis to Prognosis
by: Guillem Casas, et al.
Published: (2022-01-01)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
by: Takeru Nabeta, et al.
Published: (2021-02-01)

Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy
by: Alberto Cipriani, et al.
Published: (2020-03-01)

Genetic predisposition study of heart failure and its association with cardiomyopathy
by: Vaishak Kaviarasan, et al.
Published: (2022-01-01)

Peripartum Cardiomyopathy
by: Riccardo Raddino, et al.
Published: (2016-01-01)

Overview of the 2023 ESC guidelines for the management of cardiomyopathies
by: Yuriy Ivaniv, et al.
Published: (2023-12-01)

Surgical revascularisation of the heart in patients with chronic ischaemic cardiomyopathy and left ventricular ejection fraction of less than 30%
by: Velinović Miloš, et al.
Published: (2005-01-01)